Our Laboratory of Precision and Nanomedicine is proud to announce a recent feature article in the Estonian daily newspaper Eesti Päevaleht and news portal Delfi on October 11, 2023. The article delves into the impactful research conducted at the lab and explores the potential clinical implications of our work in the field of anticancer drug development.
In the feature, Professor Tambet Teesalu offers a comprehensive overview of the ongoing research initiatives within the laboratory. He sheds light on the innovative approaches being explored and discusses how these endeavors could lead to the development of more efficacious and better-tolerated anticancer drugs.
For a detailed insight into the interview and to explore the groundbreaking advancements in cancer treatment technology, you can read the full article here: Estonian Daily Eesti Päevaleht Feature.
We extend our gratitude to Eesti Päevaleht/Delfi for highlighting our research efforts, and we remain committed to pushing the boundaries of precision and nanomedicine for the advancement of cancer therapeutics. Stay tuned for more updates on our exciting journey.